Currently browsing tag

remaining

Pfizer hikes U.S. prices for over 100 drugs on January 1

Pfizer Inc , which plans a $160-billion merger with Ireland-based Allergan Plc to slash its U.S. tax bill, on Jan. 1 raised U.S. prices for more than 100 of its drugs, some by as much as 20 percent, according to statistics compiled by global information services company Wolters Kluwer. Company spokesman Steven Danehy could not immediately confirm the remaining price increases, which were compiled by a unit of Wolters Kluwer Health and published in a research note by UBS Securities.

Raise minimum age to buy cigarettes to decrease use: U.S. study

By Yasmeen Abutaleb NEW YORK (Reuters) – Raising the minimum age to purchase tobacco products to 21 or 25 years old would significantly reduce their use and tobacco-related illnesses in the United States, a study published Thursday found, suggesting that states and local authorities should consider passing such laws. The U.S. Food and Drug Administration, which sponsored the report, cannot increase the minimum age to buy tobacco in the country from 18, but states and local authorities can do so. The report was presented to the FDA on Tuesday, said Richard Bonnie, chair of the report committee. Among people who smoked daily, 90 percent had tried their first cigarette before the age of 19 while the remaining 10 percent had tried tobacco products by 26, the study found.